A Four-Point Screening Method for Assessing Molecular Mechanism of Action (MMOA) Identifies Tideglusib as a Time-Dependent Inhibitor of Trypanosoma brucei GSK3β.
New therapeutics are needed for neglected tropical diseases including Human African trypanosomiasis (HAT), a progressive and fatal disease caused by the protozoan parasites Trypanosoma brucei gambiense and T. b. rhodesiense. There is a need for simple, efficient, cost effective methods to identify n...
Saved in:
Main Authors: | Zachary T Swinney (Author), Brad A Haubrich (Author), Shuangluo Xia (Author), Chakk Ramesha (Author), Stephen R Gomez (Author), Paul Guyett (Author), Kojo Mensa-Wilmot (Author), David C Swinney (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2016-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phylogeography and taxonomy of Trypanosoma brucei.
by: Oliver Balmer, et al.
Published: (2011) -
Genetic control of resistance to Trypanosoma brucei brucei infection in mice.
by: Matyáš Síma, et al.
Published: (2011) -
EFFECT OF TIDEGLUSIB WITH BONE GRAFTING ON NEW BONE FORMATION
by: Ufuk Taşdemir, et al.
Published: (2021) -
Tideglusib, a prospective alternative to nonoxynol-9 contraceptive
by: Zhiting Chen, et al.
Published: (2019) -
Performance of diagnostic tests for Trypanosoma brucei brucei in experimentally infected pigs.
by: Kadidiata Ilboudo, et al.
Published: (2023)